Key points for investors:
- Strong top-line growth: Q1 revenue RMB 1.24 billion, up 64.8% year‑over‑year. Insurance-related revenue was RMB 1.15 billion, up 74.1% YoY. Non-insurance businesses remain a small portion (~7.8% of revenue).
- Profitability and margins: Operating profit for the quarter was ~RMB 79.95 million (a modest 5.3% YoY increase). Net profit attributable to ordinary shareholders was ~RMB 98.4 million, down 9.1% YoY. Insurance operating margin in Q1 was 13.3% and improved quarter‑over‑quarter by ~2 percentage points after cutting lower‑ROI channels.
- Growth strategy and investment: Management is prioritizing growth and will increase marketing/traffic investment and user‑acquisition spending. For 2026 they are targeting approximately 40% top‑line growth while aiming to keep operating profit scale broadly stable (short‑term investment for longer‑term profit potential).
- Heavy AI and tech push: Company is transitioning toward an AI‑native business — reported 75 LLM‑related patent applications (including 9 international) and recent national invention patents in semantic understanding and multimodal recognition. AI is being applied across customer service, underwriting, claims, and internal agent tools.
- Operational impact from AI: AI user‑facing applications now handle ~1 million service interactions per month and internal AI tools (cloud copilot, low‑cost AI platform) have materially improved consultant productivity and underwriting/support workflows.
- Sales & marketing and cost dynamics: Sales & marketing expenses rose substantially to RMB 541 million (driven by scaled traffic investment). Total operating costs and expenses were ~RMB 1.16 billion, up ~71.5% YoY. Some cost categories (G&A) improved slightly.
- Capital returns and balance sheet: The company completed its fifth cash dividend (~USD 10.8 million) and continued share repurchases (cumulative repurchases cited ~USD 61.8 million ADF in open market; cumulative dividends + buybacks since IPO ~USD 170 million). Cash, cash equivalents and short‑term investments were ~RMB 2.88 billion as of March 31.
- Charity and healthcare businesses: Waterdrop Charity has supported 3.75 million patients with cumulative donations of RMB 73.5 billion and partners with 119 charities. Digital clinical trial business has enrolled >15,500 patients and is growing; the company secured an intelligent drug patient matching national patent.
- Guidance/Outlook: Management reiterates growth as top priority for the year, expects to step up marketing investment now to drive larger profit potential later and expand user‑based extensions to support long‑term development.
Sign In
Buy WDH
